AU2012212591A1 - High protein nutritional compositions and methods of making and using same - Google Patents

High protein nutritional compositions and methods of making and using same Download PDF

Info

Publication number
AU2012212591A1
AU2012212591A1 AU2012212591A AU2012212591A AU2012212591A1 AU 2012212591 A1 AU2012212591 A1 AU 2012212591A1 AU 2012212591 A AU2012212591 A AU 2012212591A AU 2012212591 A AU2012212591 A AU 2012212591A AU 2012212591 A1 AU2012212591 A1 AU 2012212591A1
Authority
AU
Australia
Prior art keywords
protein
omega
nutritional composition
patient
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012212591A
Other languages
English (en)
Inventor
Doug Bolster
Norman Alan Greenberg
Zamzam Kabiry ROUGHEAD (Fariba)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45554910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2012212591(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec SA filed Critical Nestec SA
Publication of AU2012212591A1 publication Critical patent/AU2012212591A1/en
Priority to AU2016201327A priority Critical patent/AU2016201327A1/en
Priority to AU2017225011A priority patent/AU2017225011B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2012212591A 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same Abandoned AU2012212591A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2016201327A AU2016201327A1 (en) 2011-02-02 2016-03-01 High protein nutritional compositions and methods of making and using same
AU2017225011A AU2017225011B2 (en) 2011-02-02 2017-09-05 High protein nutritional compositions and methods of making and using same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161438804P 2011-02-02 2011-02-02
US61/438,804 2011-02-02
PCT/US2012/022726 WO2012106179A1 (en) 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016201327A Division AU2016201327A1 (en) 2011-02-02 2016-03-01 High protein nutritional compositions and methods of making and using same

Publications (1)

Publication Number Publication Date
AU2012212591A1 true AU2012212591A1 (en) 2013-07-25

Family

ID=45554910

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2012212591A Abandoned AU2012212591A1 (en) 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same
AU2016201327A Abandoned AU2016201327A1 (en) 2011-02-02 2016-03-01 High protein nutritional compositions and methods of making and using same
AU2017225011A Active AU2017225011B2 (en) 2011-02-02 2017-09-05 High protein nutritional compositions and methods of making and using same

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2016201327A Abandoned AU2016201327A1 (en) 2011-02-02 2016-03-01 High protein nutritional compositions and methods of making and using same
AU2017225011A Active AU2017225011B2 (en) 2011-02-02 2017-09-05 High protein nutritional compositions and methods of making and using same

Country Status (14)

Country Link
US (1) US9930908B2 (cg-RX-API-DMAC7.html)
EP (1) EP2670262B2 (cg-RX-API-DMAC7.html)
JP (1) JP6034805B2 (cg-RX-API-DMAC7.html)
CN (1) CN103347403B (cg-RX-API-DMAC7.html)
AU (3) AU2012212591A1 (cg-RX-API-DMAC7.html)
BR (1) BR112013019677B1 (cg-RX-API-DMAC7.html)
CA (1) CA2824591C (cg-RX-API-DMAC7.html)
ES (1) ES2882806T3 (cg-RX-API-DMAC7.html)
MX (1) MX2013009007A (cg-RX-API-DMAC7.html)
PH (1) PH12013501433A1 (cg-RX-API-DMAC7.html)
RU (1) RU2013140443A (cg-RX-API-DMAC7.html)
SG (1) SG191428A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012106179A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201306543B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6034805B2 (ja) 2011-02-02 2016-11-30 ネステク ソシエテ アノニム 高タンパク質栄養組成物並びにその製造方法及び使用方法
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
NZ711956A (en) 2013-03-08 2018-06-29 Axiom Foods Inc Rice protein supplements
WO2015095570A2 (en) * 2013-12-19 2015-06-25 Abbott Laboratories Nutritional composition comprising hydrolyzed protein
CN105212042A (zh) * 2014-06-30 2016-01-06 罗汉斐 一种小麦发酵营养食品及其制作方法
WO2018209131A1 (en) 2017-05-12 2018-11-15 Axiom Foods, Inc. Rice products and systems and methods for making thereof
US10806169B2 (en) 2018-05-15 2020-10-20 Kate Farms, Inc. Hydrolyzed pea protein-based nutrient composition
US20190374569A1 (en) * 2018-06-12 2019-12-12 Richard Laver Intact pea protein-based nutrient composition
CN112367848A (zh) * 2018-06-14 2021-02-12 马斯公司 用于支持患有癌症的动物的组合物
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses
BR112021009729A2 (pt) 2018-11-20 2021-08-17 Fonterra Co-Operative Group Limited produto e processo lácteo
FR3093427B1 (fr) * 2019-03-05 2021-03-05 Mativa Tech Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
BR112021021015A2 (pt) * 2019-05-31 2021-12-14 Nestle Sa Mistura de nutrientes à base de triglicerídeos de cadeia média (tcm) para fornecer benefícios de saúde a animais
AR120346A1 (es) * 2019-10-31 2022-02-09 Idemitsu Kosan Co Agente para suprimir la resistencia a la insulina en rumiantes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140304A (en) 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5714472A (en) 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
DK0754001T3 (da) 1994-04-01 2002-05-13 Abbott Lab Næringsmiddelprodukt til behandling af colitis ulcerosa og anvendelse deraf
US5776913A (en) 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
ES2211151T3 (es) * 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
US20040121044A1 (en) * 2001-03-14 2004-06-24 John Tiano Nutritional product with high protein, low carbohydrate content and good physical stability
AU2002254309B2 (en) * 2001-03-20 2006-02-02 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
SE526943C2 (sv) 2002-08-26 2005-11-22 Indevex Ab Födoämneskompositionsprodukt
US20040225022A1 (en) 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
JP4699901B2 (ja) * 2003-09-02 2011-06-15 ジェレックスインターナショナル株式会社 体脂肪代謝機能と燃焼エネルギーの活用機能とを備えているダイエット用添加物質
US7759507B2 (en) 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
EP1723951A1 (en) 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
MXPA06015203A (es) * 2004-07-01 2007-03-27 Nestec Sa Formulacion de dieta para osteoartritis canina.
EP1797891A4 (en) * 2004-09-22 2011-03-16 Ajinomoto Kk TOTAL ENTERAL FOOD COMPOSITION
EP1921928A1 (en) * 2005-08-26 2008-05-21 Nestec S.A. Nutrition for obese patients
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
EP1971230A2 (en) 2006-01-09 2008-09-24 Nestec S.A. Treatment of stressed patients
WO2007108827A1 (en) * 2006-03-23 2007-09-27 Nestec S.A. High-calorie nutritional supplement
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
EP2374452B1 (en) 2008-12-05 2019-07-24 Ajinomoto Co., Inc. Nutrient composition
JP6034805B2 (ja) 2011-02-02 2016-11-30 ネステク ソシエテ アノニム 高タンパク質栄養組成物並びにその製造方法及び使用方法

Also Published As

Publication number Publication date
MX2013009007A (es) 2013-08-29
JP2014505702A (ja) 2014-03-06
AU2016201327A1 (en) 2016-03-17
PH12013501433A1 (en) 2013-09-09
EP2670262B2 (en) 2025-10-15
CN103347403A (zh) 2013-10-09
EP2670262B1 (en) 2021-06-30
US9930908B2 (en) 2018-04-03
SG191428A1 (en) 2013-08-30
AU2017225011A1 (en) 2017-09-28
JP6034805B2 (ja) 2016-11-30
BR112013019677A2 (pt) 2017-03-21
AU2017225011B2 (en) 2019-07-18
RU2013140443A (ru) 2015-03-10
EP2670262A1 (en) 2013-12-11
BR112013019677B1 (pt) 2019-10-08
ES2882806T3 (es) 2021-12-02
CA2824591A1 (en) 2012-08-09
WO2012106179A1 (en) 2012-08-09
CA2824591C (en) 2019-02-05
US20140308390A1 (en) 2014-10-16
ZA201306543B (en) 2015-03-25
CN103347403B (zh) 2016-04-20

Similar Documents

Publication Publication Date Title
AU2017225011B2 (en) High protein nutritional compositions and methods of making and using same
US9538778B2 (en) Stable thickener formulations
AU2012241895A1 (en) Nutritional compositions including branched chain fatty acids for wound healing
US20130210715A1 (en) Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted